Portal Venous Pressure as a Predictor of Mortality in Child’s A Cirrhotic Patients Undergoing Elective Surgery: A Prospective Study
DOI:
https://doi.org/10.3889/oamjms.2020.3373Keywords:
Cirrhosis, Portal venous pressure, MortalityAbstract
BACKGROUND: Recently, portal venous pressure (PVP) exhibited high sensitivity and specificity in anticipating death in cirrhotic cases submitted to emergency operations.
AIM: The current prospective work aimed to evaluate the utility of PVP in predicting 1st month post-operative death in Child’s A cirrhotic cases who underwent elective operations.
METHODS: One-hundred and twenty cirrhotic cases that were planned to undergo elective surgery were enrolled in the current prospective work. The intraoperative (I.O) PVP and central venous pressure (CVP) were measured. The statistical analysis was performed using the SPSS version 22.0. The receiver operative curve was plotted to measure the predictive value of PVP. Multivariate analysis was done using logistic regression method for the significant variables impacting mortality on univariate analysis.
RESULTS: Twenty-nine patients died in the current work. Patients who survived had statistically considerably lower PVP than patients who died (8.2 ± 1.5 vs. 12.5 ± 1.6 mmHg, respectively, p < 0.001). Similarly, patients who died had significantly higher I.O CVP (p < 0.001), body mass index (p < 0.001), and were more likely to have model for end-stage liver disease score between 9 and 16 (p = 0.003). At a cutoff value ≥10.5 mmHg, the PVP had a sensitivity of 82.8% and specificity of 93.4% for the prediction of mortality. The logistic regression analysis showed that only PVP (odds ratio [OR] =3.1, 95% confidence interval [CI] 1.25–7.5) and CVP (OR = 2.8, 95% CI 1.2–6.5) were the only independent predictors of mortality.
CONCLUSION: PVP is a significant predictor of death in Child’s A cirrhotic cases submitted to elective operations.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol. 2014;20(18):5442-60. PMid:24833875
Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197-223. https://doi.org/10.1016/s0140-6736(12)61690-0 PMid:23245608
Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med. 2014;12:145. https://doi.org/10.1186/s12916-014-0145-y PMid:25242656
Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: Part 1 of a series on liver cirrhosis. Dtsch Arztebl Int. 2013;110(6):85-91. https://doi.org/10.3238/arztebl.2013.0085 PMid:23451000
Heidelbaugh JJ, Sherbondy M. Cirrhosis and chronic liver failure: Part II. Complications and treatment. Am Fam Physician. 2006;74(5):767-76. PMid:16970020
Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123-33. https://doi.org/10.1002/hep.29466 PMid:28802062
Demetriades D, Constantinou C, Salim A, Velmahos G, Rhee P, Chan L. Liver cirrhosis in patients undergoing laparotomy for trauma: Effect on outcomes. J Am Coll Surg. 2004;199(4):538- 42. https://doi.org/10.1016/j.jamcollsurg.2004.06.017 PMid:15454135
Millwala F, Nguyen GC, Thuluvath PJ. Outcomes of patients with cirrhosis undergoing non-hepatic surgery: Risk assessment and management. World J Gastroenterol. 2007;13(30):4056-63. https://doi.org/10.3748/wjg.v13.i30.4056 PMid:17696222
Keegan MT, Plevak DJ. Preoperative assessment of the patient with liver disease. Am J Gastroenterol. 2005;100(9):2116-27. PMid:16128958
Ziser A, Plevak DJ. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Curr Opin Anesthesiol. 2001; 14(6):707-11.
Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242(2):244-51. https://doi.org/10.1097/01.sla.0000171327.29262.e0 PMid:16041215
Kumar A, Sharma P, Sarin SK. Hepatic venous pressure gradient measurement: Time to learn! Indian J Gastroenterol. 2008;27(2):74-80. PMid:18695309
Elbarbary A, Elbedewy M, Elbadry A. Hemodynamic analysis of portal hypertension in patients with liver cirrhosis. Tanta Med J. 2014;42(4):130. https://doi.org/10.4103/1110-1415.145276
Kanematsu T, Furui J, Yanaga K, Okudaira S, Kamohara Y, Eguchi S. Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma. Hepatogastroenterology. 52(66):1828-31. PMid:16334786
Patch D, Armonis A, Sabin C, Christopoulou K, Greenslade L, McCormick A, et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut. 1999;44(2):264-9. https://doi.org/10.1136/gut.44.2.264 PMid:9895388
Salman MA, Mansour DA, Balamoun HA, Elbarmelgi MY, Hadad KE, Abo Taleb ME, et al. Portal venous pressure as a predictor of mortality in cirrhotic patients undergoing emergency surgery. Asian J Surg. 2019;42(1):338-42. https:// doi.org/10.1016/j.asjsur.2018.09.007 PMid:30316666
Elm E Von, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-9. https://doi.org/10.1016/j.ijsu.2014.07.013 PMid:25046131
Nuttall FQ. Body mass index: Obesity, BMI, and health: A critical review. Nutr Today. 2015; 50(3):117-28. PMid:27340299
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. https://doi. org/10.2337/dc11-s011 PMid:30165516
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension: The task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. J Hypertens. 2018;36(10):1953-2041. https://doi.org/10.1201/b17072-61 PMid:30234752
Xu G, Li F, Mao Y. Portal pressure monitoring-state-of-the-art and future perspective. Ann Transl Med. 2019;7(20):583. https:// doi.org/10.21037/atm.2019.09.22 PMid:31807564
Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192-204. PMid:20697561
Rai R, Nagral S, Nagral A. Surgery in a patient with liver disease. J Clin Exp Hepatol. 2012;2(3):238-46. PMid:25755440
Nguyen GC, Correia AJ, Thuluvath PJ. The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: A nationwide, population-based study. Dis Colon Rectum. 2009;52(8):1367-74. https://doi.org/10.1007/ dcr.0b013e3181a80dca PMid:19617746
Gil A, Martínez-Regueira F, Hernández-Lizoain JL, Pardo F, Olea JM, Bastarrika G, et al. The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol. 2004;30(1):46-52. https://doi.org/10.1016/j.ejso.2003.10.014 PMid:14736522
Kim JJ, Dasika NL, Yu E, Fontana RJ. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery. J Clin Gastroenterol. 2009;43(6):574-9. https://doi.org/10.1097/mcg.0b013e31818738ef PMid:19169145
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864-71. https://doi.org/10.1053/he.2000.5852 PMid:10733541
O’Leary JG, Friedman LS. Predicting surgical risk in patients with cirrhosis: From art to science. Gastroenterology. 2007;132(4):1609- 11. https://doi.org/10.1053/j.gastro.2007.03.016 PMid:17428482
Hemida K, Al Swaff RE, Shabana SS, Said H, Ali-Eldin F. Prediction of post-operative mortality in patients with HCV-related cirrhosis undergoing non-hepatic surgeries. J Clin Diagn Res. 2016;10(10):OC18-21. https://doi.org/10.7860/ jcdr/2016/22478.8620 PMid:27891371
Havens JM, Columbus AB, Olufajo OA, Askari R, Salim A, Christopher KB. Association of model for end-stage liver disease score with mortality in emergency general surgery patients. JAMA Surg. 2016;151(7):e160789. https://doi.org/10.1001/ jamasurg.2016.0789 PMid:27192189578
Downloads
Published
How to Cite
License
Copyright (c) 2020 Mohamed El-Ghobary, Ahmed Abdallah Salman, Hossam El-Din Shaaban, Mohamed Saber Mostafa, Mohamed Sabry Tourky, Ossama Ramzy Youssef, Mahmoud Gouda Omar (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0